Andrew Combs - Insider Trading & Ownership

Entity
Individual
Location
C/O Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington, DE
Summary
The estimated net worth of Andrew Combs is at least $516K dollars as of February 5, 2025. Andrew Combs is the Chief Chemistry Officer of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $516K.
All Insider Reports
All Insider Reports

Ownership of Andrew Combs

Insider Transactions Reported by Andrew Combs:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.